Cangene Corporation, based in Winnipeg, Canada, specializes in the development and manufacturing of biopharmaceutical products. The company focuses on therapeutic proteins and monoclonal antibodies, particularly in the areas of infectious diseases and immunology. Cangene is dedicated to advancing medical treatments through innovative research and technology, contributing to the healthcare landscape with its expertise in biologics and drug development. Its commitment to quality and efficacy positions it as a key player in the biopharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#14 in Winnipeg

#1,166 in Canada

#45,081 in the World

Winnipeg, Canada

Cangene Corporation

Forward Citations = 1,507

25 inventors:

Lawrence T Malek (8 out of 14 patents)

David L Jenish (3 out of 3 patents)

Michael J Butler (3 out of 3 patents)

4. Gisela Soostmeyer (3 out of 3 patents)

5. Timothy J Krieger (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cangene Corporation. Retrieved from https://idiyas.com/company/cangene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]